DEVELOPMENT AND EVALUATION OF PHYTOSOMES OF Artemisia vulgaris L. FOR ANTICANCER ACTIVITY
Authors: Sundaraganapathy R , GAYATHRI.K, KUMUDHA.D, THABSEERA.N, UVAIS.T, SUREKA.M, SURYA PRAKASH.R, VELLAISAMY.R, VYSHNA.V AND S MOHAN

ABSTRACT
Cancer is a major public health issue associated with significant death and disability. Breast cancer is second and very common type of cancer in women worldwide. Artemisia vulgaris L. (Mugwort), family Asteraceae, has been used to treat various diseases. Since ancient times the Indians were used Artemisia vulgaris L. to treat imbalances that women may suffer such as Breast cancer, Premenstrual syndrome, Dysmenorrheal, Menopause and anti-fertility. The term “Phyto” means plant while “Some” means cell like. Phytosomes are little cell-like structure. Phytosomes are recently introduced herbal formulation which contains phytoconstituents that are better absorbed and as a result produce better bioavailability and pharmacological actions. Phytosomes are novel patented technology to develop and incorporate the standardized plant extract into phospholipids to produce lipid compatible molecular complexes. The Phytosomes are developed from the ethanolic extract of Artemisia vulgaris L. by anti-solvent precipitation method, characterized and evaluated for anticancer activity. Keywords: Artemisia vulgaris L., Anticancer, Phytosomes, Breast Cancer
Publication date: 01/03/2020
    https://ijbpas.com/pdf/2020/March/MS_IJBPAS_2020_4975.pdf
Download PDF
https://doi.org/10.31032/IJBPAS/2020/9.3.4975